首页|抗晕动病药物及其缓控释制剂的研究进展

抗晕动病药物及其缓控释制剂的研究进展

扫码查看
晕动病是指机体在异常运动下受到刺激而引起的一系列生理反应,常见症状有头晕、呕吐等.目前,抗晕动病药物主要有抗组胺药、抗胆碱药、钙拮抗药、拟交感神经药、胃动力药,且多数为普通制剂,而缓控释制剂的研发及应用较少.本文对晕动病的发病机制、治疗药物分类以及抗晕动病药物缓控释制剂,如透皮制剂、鼻用制剂和口服制剂的研究进展进行综述,分析目前晕动病防治研究过程中存在的问题,为抗晕动病药物新剂型的研发提供新思路.
Progress on anti-motion sickness drugs and their sustained-release preparations
Motion sickness(MS)is a series of physiological responses such as dizziness and vomiting in human being caused by abnormal movement stimulation.Recently,most of anti-motion sickness drugs mainly include antihistamines,anticholinergic drugs,calcium antagonists,sympathomimetic drugs,and gastric motility drugs,and most of them are common preparations,while the development and application of sustained-release preparations are few.This article reviews the pathogenesis of motion sickness,the classification of therapeutic drugs and sustained-release preparations,including transdermal preparations,nasal preparations and oral preparations.Besides,this article also points out the problems and gives some advice during the current research of anti-motion sickness drugs,which will provide new methods for developing new preparations of anti-motion sickness.

motion sickness drugmechanismsustained-release preparation

杨紫瑜、劳杰铿、林华庆

展开 >

广东药科大学广东省药物新剂型重点实验室,广东 广州 510006

晕动病药物 发病机制 缓控释制剂

广东省科技厅-广东省中医药科学院联合科研项目广东省手性药物创新平台建设项目

2016A0202260382013B090800007

2024

广东药科大学学报
广东药学院

广东药科大学学报

CSTPCD
影响因子:0.698
ISSN:1006-8783
年,卷(期):2024.40(3)